Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile

By Sim B.K.L.  

Angiogenesis, Vol. 3, Iss. 1, 1999-01 ,pp. : 41-51

Springer Publishing Company

Access to resources Recommend Favorite

Activation of recombinant human protein C

By Lee T.K.   Bangalore N.   Drohan W.N.   Lubon H.   Velander W.  

Thrombosis Research, Vol. 82, Iss. 3, 1996-05 ,pp. : 225-234

Elsevier

Access to resources Recommend Favorite

Human Studies of Recombinant Human Nerve Growth Factor and Diabetic Peripheral Neuropathy

By  

European Neurology, Vol. 41, Iss. 1, 1999-02 ,pp. : 20-26

Karger

Access to resources Recommend Favorite

Qualitative and quantitative detection of human and recombinant thrombin by binding to leech and recombinant hirudin immobilized at the solid phase

By Fischer B.E.   Mitterer A.   Dorner F.  

Thrombosis Research, Vol. 81, Iss. 1, 1996-01 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite

Effects of Binding of Ligand (FVIIa) to Induced Tissue Factor in Human Endothelial Cells

By Wiiger M.T.   Pringle S.   Pettersen K.S.   Narahara  

Thrombosis Research, Vol. 98, Iss. 4, 2000-05 ,pp. : 311-321

Elsevier

Access to resources Recommend Favorite